beta-lactamases exist
β-内酰胺酶存在
detecting beta-lactamases
检测β-内酰胺酶
beta-lactamase production
β-内酰胺酶产生
beta-lactamases inhibit
β-内酰胺酶抑制
clinical beta-lactamases
临床β-内酰胺酶
beta-lactamase genes
β-内酰胺酶基因
beta-lactamases degrade
β-内酰胺酶降解
beta-lactamase activity
β-内酰胺酶活性
beta-lactamases spread
β-内酰胺酶传播
beta-lactamase testing
β-内酰胺酶检测
the study investigated the prevalence of beta-lactamases in clinical isolates.
该研究调查了临床分离株中β-内酰胺酶的流行程度。
emerging beta-lactamase variants pose a significant threat to antibiotic efficacy.
新出现的β-内酰胺酶变异株对抗菌药物的有效性构成重大威胁。
patients with infections caused by beta-lactamase-producing bacteria require alternative therapies.
感染由产生β-内酰胺酶的细菌引起的患者需要替代疗法。
rapid detection of beta-lactamases is crucial for guiding antibiotic stewardship programs.
快速检测β-内酰胺酶对于指导抗菌药物管理计划至关重要。
carbapenemase beta-lactamases are particularly concerning due to their broad spectrum of activity.
碳青霉烯酶β-内酰胺酶尤其令人担忧，因为它们具有广泛的活性谱。
researchers are developing novel inhibitors to overcome beta-lactamase resistance.
研究人员正在开发新型抑制剂以克服β-内酰胺酶耐药性。
the presence of extended-spectrum beta-lactamases (esbls) is a growing public health concern.
扩展谱β-内酰胺酶（esbl）的存在是一个日益增长的公共卫生问题。
beta-lactamase genes are often located on mobile genetic elements, facilitating their spread.
β-内酰胺酶基因通常位于可移动遗传元件上，促进了它们的传播。
clinical laboratories routinely screen for beta-lactamases in bacterial isolates.
临床实验室常规对细菌分离株进行β-内酰胺酶筛查。
the increased incidence of beta-lactamase production necessitates new diagnostic approaches.
β-内酰胺酶产生的发病率增加，需要新的诊断方法。
understanding beta-lactamase mechanisms is essential for developing effective antibiotics.
理解β-内酰胺酶机制对于开发有效的抗菌药物至关重要。
beta-lactamases exist
β-内酰胺酶存在
detecting beta-lactamases
检测β-内酰胺酶
beta-lactamase production
β-内酰胺酶产生
beta-lactamases inhibit
β-内酰胺酶抑制
clinical beta-lactamases
临床β-内酰胺酶
beta-lactamase genes
β-内酰胺酶基因
beta-lactamases degrade
β-内酰胺酶降解
beta-lactamase activity
β-内酰胺酶活性
beta-lactamases spread
β-内酰胺酶传播
beta-lactamase testing
β-内酰胺酶检测
the study investigated the prevalence of beta-lactamases in clinical isolates.
该研究调查了临床分离株中β-内酰胺酶的流行程度。
emerging beta-lactamase variants pose a significant threat to antibiotic efficacy.
新出现的β-内酰胺酶变异株对抗菌药物的有效性构成重大威胁。
patients with infections caused by beta-lactamase-producing bacteria require alternative therapies.
感染由产生β-内酰胺酶的细菌引起的患者需要替代疗法。
rapid detection of beta-lactamases is crucial for guiding antibiotic stewardship programs.
快速检测β-内酰胺酶对于指导抗菌药物管理计划至关重要。
carbapenemase beta-lactamases are particularly concerning due to their broad spectrum of activity.
碳青霉烯酶β-内酰胺酶尤其令人担忧，因为它们具有广泛的活性谱。
researchers are developing novel inhibitors to overcome beta-lactamase resistance.
研究人员正在开发新型抑制剂以克服β-内酰胺酶耐药性。
the presence of extended-spectrum beta-lactamases (esbls) is a growing public health concern.
扩展谱β-内酰胺酶（esbl）的存在是一个日益增长的公共卫生问题。
beta-lactamase genes are often located on mobile genetic elements, facilitating their spread.
β-内酰胺酶基因通常位于可移动遗传元件上，促进了它们的传播。
clinical laboratories routinely screen for beta-lactamases in bacterial isolates.
临床实验室常规对细菌分离株进行β-内酰胺酶筛查。
the increased incidence of beta-lactamase production necessitates new diagnostic approaches.
β-内酰胺酶产生的发病率增加，需要新的诊断方法。
understanding beta-lactamase mechanisms is essential for developing effective antibiotics.
理解β-内酰胺酶机制对于开发有效的抗菌药物至关重要。
探索常用高频词汇